Quarterly Earnings

Essent Group boosts its dividend after a strong 2025, returning $700M to shareholders while making a strategic leap into the global P&C reinsurance market.

Magna beat Q4 expectations and raised its dividend, but a $591M tech impairment and looming Ford recall costs paint a complex picture for the auto giant.

Vitalist reports soaring losses and a $6.4M debt surge, raising 'going concern' alarms. Can its new Reebok smartwatches and VitalOS™ platform save it?

With strong financials and a focus on tech, Allegion's CEO will outline the security giant's long-term strategy for a digitally connected world.

With top executives set for major conferences, investors eye Mastercard's playbook for commercial payments and Americas growth amid fierce competition.

With a 33% revenue surge and expanding margins, Capstone Green Energy's strategic pivot to data centers and EaaS is paying off, marking a major turnaround.

With revolutionary tech and a volatile stock, PureCycle's year-end update is a critical test of its operational progress and financial promises.

The retail REIT reports record-breaking leasing and strong profits for 2025, while executing a strategic portfolio overhaul and setting a confident tone for 2026.

As Liberty Latin America preps its 2025 results, investors watch to see if strong subscriber growth and cost-cutting can sustain momentum in a competitive market.

Investors eye Globus Medical's upcoming report for a full-year look at its NuVasive integration, market trends, and a pivotal 2025 performance.

Brazil's fintech leader reports a record R$5.2B adjusted net income for 2025, outlining a strategy that pairs AI with human advisors to win the market.

Ubisoft reports booming Q3 sales fueled by its top franchises, but a major restructuring, job cuts, and a grim profit forecast paint a complex picture.

Datasea's profits are booming despite a revenue drop, as it pivots to high-margin AI and futuristic acoustic tech. Is this a genius move or a risky gamble?

Skycorp Solar reported a 27% revenue surge driven by global expansion, but intense competition and rising costs led to a surprising net loss.

As BJ’s prepares to report Q4 results, investors are watching if a pizza relaunch and new efficiencies can overcome industry-wide cost pressures.

Bio-Techne promotes Steve Crouse to lead its high-growth Diagnostics and Spatial Biology unit, signaling a strategic focus on innovation after a key divestiture.

With triple-digit growth, the firm's partner-led model is dominating the market as companies race to defend against escalating third-party cyber threats.

Exodus reports a surge in users and swap volume for January, defying a market downturn while strategically increasing its Solana treasury holdings.

LiveOne is set to announce three new Fortune 500 partnerships alongside better-than-expected Q3 results, signaling a major push into the enterprise market.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.